There are no important new data on the aetiology of @entity29 . However, some new data were presented on the possible importance of certain nutrients or drugs in the genesis of the disease, as well as other data related to genetic features and their relationship with the microbiota. A highly interesting study suggested the strong potential of serological studies in predicting the course of @entity30 . The value of magnetic resonance imaging and the potential of low-radiation-dose tomography were reaffirmed in the monitoring and follow-up of @entity1 and their treatments. Studies also confirmed the utility confirmed of new (and more comfortable) methods of home measurement of faecal calprotectin levels. In individualized therapy, attempts are being made to increase the practical application of new results on anti- @entity310 levels and their antibodies, for example, by identifying the utility of non-trough levels. We believe that the results presented on the impact of the disease on @entity1 themselves were especially important, from their own perspective and in diverse setting. This impact is important both for @entity1 (not only because of the repercussions of the disease on their quality of life but also on their mental health, disability, stress, and financial situation, etc.) and for their families. Finally, interesting results were presented of well-performed studies on @entity14 prevention in @entity29 . These results confirm chromoendoscopy as a key technique but suggest that technological advances could change this situation, thus simplifying prevention.

[Epidemiology, follow-up, monitoring and other aspects of XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity310 :: ('7124', 'Gene') :: ['TNF'] @entity29 :: ('MESH:D015212', 'Disease') :: ['inflammatory bowel disease'] @entity14 :: ('MESH:D015179', 'Disease') :: ['colorectal cancer'] @entity30 :: ('MESH:D003424', 'Disease') :: ["Crohn's disease"]
@entity29 :: (MESH:D015212,Disease) :: ['inflammatory bowel disease']
